New study tailors surgery and radiation to each Patient's response in advanced breast cancer

NCT ID NCT07376538

Recruiting now Disease control Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for women with advanced breast cancer that has spread to nearby lymph nodes. After initial chemotherapy, doctors will adjust the next steps—surgery and radiation—based on how much cancer remains. The goal is to see if this personalized approach can help people live longer without the cancer coming back. About 157 participants will be enrolled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: response-adapted radiation and surgery
What this could lead to: If successful, this could lead to more personalized, effective treatment for advanced breast cancer, potentially improving survival and reducing unnecessary procedures.
What could go wrong: This is a phase 2 trial with only 157 participants, so results may not apply to everyone. The approach is complex and may not improve outcomes or could cause side effects from intensified therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Cancer Hospital, Chinese Academy of Medical Sciences
RECRUITING

Beijing, Beijing Municipality, 100021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.